Analytical aspects of microRNA in diagnostics: a review
- PMID: 21704768
- DOI: 10.1016/j.aca.2011.05.025
Analytical aspects of microRNA in diagnostics: a review
Abstract
MicroRNAs (miRNA) are short (∼22 nucleotides) non-coding RNA molecules that regulate gene expression at the post-transcriptional level. Their expression is specific to cells and tissues and is temporally regulated. miRNAs are known to be involved in developmental and physiological processes, and their dysregulation leads to development of diseases. Since their profiles reflect pathological processes, miRNAs have recently been proposed as being useful in diagnostics as biomarkers of the onset, prognosis and risk of diseases, as well as in the classification of different types of cancer. The establishment of miRNA profiles that are representative of diseases and the detection of different types and levels of miRNA in samples are therefore critical milestones in diagnostics. miRNAs can be detected in blood and body fluids as well as in tissues, thus making non-invasive collection of samples possible. For a method to be useful in diagnostics, it should be simple, inexpensive and highly sensitive. Here, we will review current methods of detecting miRNAs and indicate the advantages and disadvantages of each techniques. We will then summarize some of the clinical evidence for the potential application of miRNAs as biomarkers in diagnostics. We conclude providing some general perspectives on the use of miRNAs in clinical situations, including therapeutic applications.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25. Biomed Pharmacother. 2010. PMID: 20363096
-
MicroRNA expression profiling in cancer from a bioinformatics prospective.Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787. Expert Rev Mol Diagn. 2007. PMID: 18020908 Review.
-
Detection of microRNAs in prostate cancer cells by microRNA array.Methods Mol Biol. 2011;732:69-88. doi: 10.1007/978-1-61779-083-6_6. Methods Mol Biol. 2011. PMID: 21431706
-
Strategies for profiling microRNA expression.J Cell Physiol. 2009 Jan;218(1):22-5. doi: 10.1002/jcp.21577. J Cell Physiol. 2009. PMID: 18767038 Review.
-
Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.Int J Oncol. 2011 May;38(5):1385-93. doi: 10.3892/ijo.2011.961. Epub 2011 Mar 3. Int J Oncol. 2011. PMID: 21373755
Cited by
-
Role of Nano-miRNAs in Diagnostics and Therapeutics.Int J Mol Sci. 2022 Jun 20;23(12):6836. doi: 10.3390/ijms23126836. Int J Mol Sci. 2022. PMID: 35743278 Free PMC article. Review.
-
miRNAs in the Diagnosis and Prognosis of Skin Cancer.Front Cell Dev Biol. 2020 Feb 28;8:71. doi: 10.3389/fcell.2020.00071. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32185171 Free PMC article. Review.
-
MicroRNAome genome: a treasure for cancer diagnosis and therapy.CA Cancer J Clin. 2014 Sep-Oct;64(5):311-36. doi: 10.3322/caac.21244. Epub 2014 Aug 7. CA Cancer J Clin. 2014. PMID: 25104502 Free PMC article. Review.
-
Locking-to-unlocking system is an efficient strategy to design DNA/silver nanoclusters (AgNCs) probe for human miRNAs.Nucleic Acids Res. 2016 Apr 7;44(6):e57. doi: 10.1093/nar/gkv1377. Epub 2015 Dec 17. Nucleic Acids Res. 2016. PMID: 26681688 Free PMC article.
-
Identification of Reference Genes for Analysis of microRNA Expression Patterns in Equine Chorioallantoic Membrane and Serum.Mol Biotechnol. 2018 Jan;60(1):62-73. doi: 10.1007/s12033-017-0047-2. Mol Biotechnol. 2018. PMID: 29197992
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources